Euglycemic diabetic ketoacidosis (euDKA) is a rare but serious complication of diabetes mellitus, consisting of about 3% of DKA presentations, and often associated with sodium-glucose co-transporter 2 (SGLT2) inhibitors. Here, SLC5A2 is linked to diabetes mellitus.